These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


855 related items for PubMed ID: 18722353

  • 1. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
    Han Y, Jin YH, Kim YJ, Kang BY, Choi HJ, Kim DW, Yeo CY, Lee KY.
    Biochem Biophys Res Commun; 2008 Oct 31; 375(4):576-80. PubMed ID: 18722353
    [Abstract] [Full Text] [Related]

  • 2. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
    Han Y, Jeong HM, Jin YH, Kim YJ, Jeong HG, Yeo CY, Lee KY.
    Biochem Biophys Res Commun; 2009 May 22; 383(1):88-92. PubMed ID: 19344692
    [Abstract] [Full Text] [Related]

  • 3. Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.
    Jin YH, Kim YJ, Kim DW, Baek KH, Kang BY, Yeo CY, Lee KY.
    Biochem Biophys Res Commun; 2008 Apr 11; 368(3):690-5. PubMed ID: 18249187
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300.
    Lu J, Sun H, Wang X, Liu C, Xu X, Li F, Huang B.
    Cytokine; 2005 Jul 07; 31(1):46-51. PubMed ID: 15869883
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibitors that target tubulin.
    Schemies J, Sippl W, Jung M.
    Cancer Lett; 2009 Aug 08; 280(2):222-32. PubMed ID: 19268440
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
    Grégoire S, Xiao L, Nie J, Zhang X, Xu M, Li J, Wong J, Seto E, Yang XJ.
    Mol Cell Biol; 2007 Feb 08; 27(4):1280-95. PubMed ID: 17158926
    [Abstract] [Full Text] [Related]

  • 7. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT, Langer MR, Slama JT, Denu JM.
    Biochemistry; 2004 Aug 03; 43(30):9877-87. PubMed ID: 15274642
    [Abstract] [Full Text] [Related]

  • 8. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
    Spange S, Wagner T, Heinzel T, Krämer OH.
    Int J Biochem Cell Biol; 2009 Jan 03; 41(1):185-98. PubMed ID: 18804549
    [Abstract] [Full Text] [Related]

  • 9. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
    Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J.
    Circ Res; 2004 Nov 12; 95(10):971-80. PubMed ID: 15486319
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
    Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE.
    Cancer Res; 2002 Nov 01; 62(21):6231-9. PubMed ID: 12414652
    [Abstract] [Full Text] [Related]

  • 11. SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis.
    Li Y, Matsumori H, Nakayama Y, Osaki M, Kojima H, Kurimasa A, Ito H, Mori S, Katoh M, Oshimura M, Inoue T.
    Genes Cells; 2011 Jan 01; 16(1):34-45. PubMed ID: 21059157
    [Abstract] [Full Text] [Related]

  • 12. The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation.
    Bell SD, Botting CH, Wardleworth BN, Jackson SP, White MF.
    Science; 2002 Apr 05; 296(5565):148-51. PubMed ID: 11935028
    [Abstract] [Full Text] [Related]

  • 13. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.
    Marcotte PA, Richardson PL, Guo J, Barrett LW, Xu N, Gunasekera A, Glaser KB.
    Anal Biochem; 2004 Sep 01; 332(1):90-9. PubMed ID: 15301953
    [Abstract] [Full Text] [Related]

  • 14. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.
    Inoue T, Hiratsuka M, Osaki M, Yamada H, Kishimoto I, Yamaguchi S, Nakano S, Katoh M, Ito H, Oshimura M.
    Oncogene; 2007 Feb 15; 26(7):945-57. PubMed ID: 16909107
    [Abstract] [Full Text] [Related]

  • 15. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR, Gu W, Dalla-Favera R.
    Nat Genet; 2002 Dec 15; 32(4):606-13. PubMed ID: 12402037
    [Abstract] [Full Text] [Related]

  • 16. FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2).
    Voelter-Mahlknecht S, Ho AD, Mahlknecht U.
    Int J Oncol; 2005 Nov 15; 27(5):1187-96. PubMed ID: 16211212
    [Abstract] [Full Text] [Related]

  • 17. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
    Vaquero A, Sternglanz R, Reinberg D.
    Oncogene; 2007 Aug 13; 26(37):5505-20. PubMed ID: 17694090
    [Abstract] [Full Text] [Related]

  • 18. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells.
    Matsushita N, Takami Y, Kimura M, Tachiiri S, Ishiai M, Nakayama T, Takata M.
    Genes Cells; 2005 Apr 13; 10(4):321-32. PubMed ID: 15773895
    [Abstract] [Full Text] [Related]

  • 19. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
    Arif M, Kumar GV, Narayana C, Kundu TK.
    J Phys Chem B; 2007 Oct 18; 111(41):11877-9. PubMed ID: 17894486
    [Abstract] [Full Text] [Related]

  • 20. Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo.
    Fenton TR, Gwalter J, Ericsson J, Gout IT.
    Int J Biochem Cell Biol; 2010 Feb 18; 42(2):359-66. PubMed ID: 19961954
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.